LGVNLongeveron Inc.

LGVN Stock Price, Valuation & Chart | Longeveron Inc.

Compare

$6.780+0.03 (+0.44%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology LGVN intrinsic value LGVN calculated fair value vs price

Overview Financials Dividends Ratios

LGVN Historical price chart

LGVN Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization20.63M

PE Ratio-6.85

EPS-0.99

Trading Volume35.88K

Today's High/Low6.98/6.67

Dividend Yield0.00

52 Week High/Low12.3/4.75

Shares Outstanding3.04M

LGVN Financial Statement

LGVN Analyst ratings

LGVN Analysis & performance metrics

LGVN Company profile

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational…

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2…

LGVN Management team

Name

Position

Joshua Michael Hare FACC, M.D.

Co-Founder, Chief Science Officer & Chairman

Lisa McClain-Moss

Vice President of Manufacturing

Devin BlassCTO

Chief Technology Officer & Senior Vice President of Chemistry, Manufacturing, and Controls

Heather Zhou

Vice President & Corporate Controller

Paul T. Lehr J.D.

General Counsel & Secretary

Nataliya Agafonova M.D.

Chief Medical Officer

Mohamed Wa'el Ahmed Hashad M.B.A.CEO

Chief Executive Officer & Director

Lisa A. Locklear M.B.A.CFO

Chief Financial Officer, Executive Vice President & Treasurer

Name

Position

Joshua Michael Hare FACC, M.D.

Co-Founder, Chief Science Officer & Chairman

Lisa McClain-Moss

Vice President of Manufacturing

Devin BlassCTO

Chief Technology Officer & Senior Vice President of Chemistry, Manufacturing, and Controls

Heather Zhou

Vice President & Corporate Controller

Paul T. Lehr J.D.

General Counsel & Secretary

Nataliya Agafonova M.D.

Chief Medical Officer

Mohamed Wa'el Ahmed Hashad M.B.A.CEO

Chief Executive Officer & Director

Lisa A. Locklear M.B.A.CFO

Chief Financial Officer, Executive Vice President & Treasurer

Management Team

Joshua Michael Hare FACC, M.D.

Co-Founder, Chief Science Officer & Chairman

Lisa McClain-Moss

Vice President of Manufacturing

Devin BlassCTO

Chief Technology Officer & Senior Vice President of Chemistry, Manufacturing, and Controls

Heather Zhou

Vice President & Corporate Controller

Paul T. Lehr J.D.

General Counsel & Secretary

Nataliya Agafonova M.D.

Chief Medical Officer

Mohamed Wa'el Ahmed Hashad M.B.A.CEO

Chief Executive Officer & Director

Lisa A. Locklear M.B.A.CFO

Chief Financial Officer, Executive Vice President & Treasurer

Management

Joshua Michael Hare FACC, M.D.

Co-Founder, Chief Science Officer & Chairman

Lisa McClain-Moss

Vice President of Manufacturing

Devin BlassCTO

Chief Technology Officer & Senior Vice President of Chemistry, Manufacturing, and Controls

Heather Zhou

Vice President & Corporate Controller

Paul T. Lehr J.D.

General Counsel & Secretary

Nataliya Agafonova M.D.

Chief Medical Officer

Mohamed Wa'el Ahmed Hashad M.B.A.CEO

Chief Executive Officer & Director

Lisa A. Locklear M.B.A.CFO

Chief Financial Officer, Executive Vice President & Treasurer

Total 8 executives

LGVN Frequently asked questions

What is Longeveron Inc. (LGVN) Stock Price?

Current stock price of Longeveron Inc. (LGVN) stock is $6.780. The stock price is +0.44% higher in the session. The intraday range can be seen from this page. Volume of Longeveron Inc. (LGVN) stock is 35.88K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Longeveron Inc. (LGVN) stock price going up or down today?

The stock price of Longeveron Inc. (LGVN) can change with earnings, company news, and overall market sentiment. Longeveron Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Longeveron Inc. stock expensive at its current price?

Whether Longeveron Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for LGVN on this page is -6.85. EPS on this page is -0.99. Compare those figures with peers and growth expectations before deciding if the current Longeveron Inc. price is justified.

How has the stock price of Longeveron Inc. (LGVN) performed historically?

Historical performance for Longeveron Inc. (LGVN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how LGVN reacted to past earnings and market events.

Should I buy Longeveron Inc. (LGVN) stock, at this price?

Buying Longeveron Inc. (LGVN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.